10don MSN
Transition of bitcoin ownership caused people to rotate into gold: Cantor Fitzgerald's Johnson
Eric Johnston, chief equity and micro strategy at Cantor Fitzgerald, joins CNBC's 'Squawk on the Street' to discuss the AI ...
Cantor Fitzgerald remains optimistic on the equity market’s trajectory through year-end, citing accelerating S&P 500 sales growth, expanding profit margins, and rising forward earnings estimates. In ...
Hosted on MSN
Cantor Fitzgerald Chairman Brandon Lutnick: SPACS are an incredible tool for the market
Cantor Fitzgerald Chairman Brandon Lutnick joins 'Closing Bell Overtime' to talk the day's record market action. Trump’s shutdown win just landed Republicans with a huge political headache Cargo plane ...
Hosted on MSN
Eric Cantor on shutdown: The Democrats have become emboldened after Tuesday's election results
Eric Cantor, Moelis and Company vice chairman and managing director and former House Majority Leader, joins 'Squawk Box' to discuss the ongoing federal government shutdown, when the could be an end in ...
Douglas Emmett, Inc. (NYSE:DEI) is included among the 15 Best 52-Week Low Dividend Stocks to Invest in. On November 6, Cantor Fitzgerald cut its price target on Douglas Emmett, Inc. (NYSE:DEI) to ...
nLIGHT, Inc. (NASDAQ:LASR) is one of the Hottest Small Cap Stocks to Buy Now. On November 7, Cantor Fitzgerald analyst Troy Jensen raised the firm’s price target on nLIGHT, Inc. (NASDAQ:LASR) from $33 ...
Hosted on MSN
Cantor Fitzgerald Downgrades Korro Bio (KRRO)
Fintel reports that on November 13, 2025, Cantor Fitzgerald downgraded their outlook for Korro Bio (NasdaqCM:KRRO) from Overweight to Neutral. Analyst Price Forecast Suggests 1,373.12% Upside As of ...
Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & ...
Fintel reports that on November 12, 2025, Cantor Fitzgerald downgraded their outlook for Astria Therapeutics (NasdaqGM:ATXS) from Overweight to Neutral. Analyst Price Forecast Suggests 110.30% Upside ...
Fintel reports that on November 13, 2025, Cantor Fitzgerald maintained coverage of SoundThinking (NasdaqCM:SSTI) with a Overweight recommendation. Analyst Price Forecast Suggests 160.14% Upside As of ...
Shares of Madrigal Pharmaceuticals (MDGL) traded sharply higher for the second straight session on Wednesday after Cantor Fitzgerald upgraded the company, arguing that the commercial rollout of its ...
Fintel reports that on November 14, 2025, Cantor Fitzgerald maintained coverage of Bitfarms (NasdaqGM:BITF) with a Overweight recommendation. Analyst Price Forecast Suggests 1.47% Downside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback